An investment in the future of food ― meet the company that is going to enable the production of real delicious, nutritious meat that’s slaughter-free.
MeaTech 3D (Nasdaq: MITC) is a global deep-tech food company developing the advanced biotechnology and engineering capabilities to produce delicious, nutritious real meat made from cells rather than slaughtered animals. The company has been advancing its bio-printing technology in order to circumvent unsustainable challenges faced by conventional animal husbandry, such as the industry’s enormous carbon footprint, water and land usage, and animal welfare issues. Importantly, MeaTech has just made an announcement confirming a significant upgrade to its technology that should help the company continue accelerating its progress toward commercialization.
MeaTech’s bio-printing advancement
At the beginning of the month, the company reported that it had successfully developed a unique multiple-nozzle modular printing head that can produce complex meat products with pinpoint precision at an industrial rate of production without impacting cell viability. The technology will give meat manufacturers and retailers the capability to produce whole cuts of meat with formations and proportions of fat and muscle tissue that mimic conventional meat.
MeaTech will also be able to accurately print repetitive fat and muscle cell combinations which will allow scaled-up production of different types of steaks and other meat products with uniformity of thickness, size, density, and shape. Essentially, producers will be able to print precisely customized meat products based on consumer demand.
This technological development is a breakthrough step toward the successful mass production of meat using cells and biomaterials. The company is addressing the scaling challenges currently facing the broader cultured meat sector as it speeds up its entry into the commercial market with the aim of becoming the leading supplier of advanced cultured meat bio-printing technology and services to third-party food-sector players.
A “hybrid” solution for accelerating commercialization in the short term
In the meantime, MeaTech’s wholly owned Belgian subsidiary, Peace of Meat, has secured a strategic collaboration with alternative protein manufacturer, ENOUGH, that they hope will propel the company into the market for hybrid food products sometime in 2023. Peace of Meat is a leading developer of cultured avian biomass. ENOUGH is a leader in the field of mycoprotein, a fungi-based fermented food ingredient.
This joint development agreement is focused on enabling the use of cultured avian biomass as an ingredient for developing hybrid food products that offer “a meatier taste and mouthfeel that is closer to conventional meat products.” The future of sustainable protein is likely to include a mix of plant-fermentation and cell-based products. Therefore, this agreement is being seen as an important and logical step on an accelerated path toward commercialization.
The stock is well positioned as the company emerges as an industry leader
MeaTech is standing out as a compelling under-the-radar investment opportunity within the cultured meat sector. As the company accelerates its transition from development stage to industry leader, it is positioning itself to become a key beneficiary of the enormous growth expected in the alternative meat market in the coming years. As this plays out, the stock is likely to benefit from growing investor interest, propelling the company into the mainstream.
Note: All information on this page is subject to change. The use of this website constitutes acceptance of our user agreement. Please read our privacy policy and legal disclaimer. Opinions expressed at FXstreet.com are those of the individual authors and do not necessarily represent the opinion of FXstreet.com or its management. Risk Disclosure: Trading foreign exchange on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest in foreign exchange you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or all of your initial investment and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with foreign exchange trading, and seek advice from an independent financial advisor if you have any doubts.
Recommended content
Editors’ Picks
EUR/USD stabilizes near 1.0800 as trading action turns subdued
EUR/USD holds steady near 1.0800 on Thursday and remains on track to end the day in negative territory following upbeat macroeconomic data releases from the US. The action in financial markets turn subdued as trading volumes thin out heading into Easter holiday.
GBP/USD extends sideways grind above 1.2600
GBP/USD fluctuates in a narrow channel above 1.2600 on Thursday. The better-than-expected Initial Jobless Claims data from the US and the upward revision to the Q4 GDP growth help the USD stay resilient against its rivals and limits the pair's upside.
Gold pulls away from daily highs, holds above $2,200
Gold retreats from daily highs but holds comfortably above $2,200 in the American session on Thursday. The benchmark 10-year US Treasury bond yield stays near 4.2% after upbeat US data and makes it difficult for XAU/USD to gather further bullish momentum.
XRP price falls to $0.60 support as Ripple ruling doesn’t help Coinbase lawsuit against SEC
XRP programmatic sales ruling by Judge Torres was completely rejected by another US Court that ruled in favor of the SEC in a lawsuit against Coinbase.
Portfolio rebalancing and reflation trades emerge into Q2
Yesterday’s price action pointed at a possible end-of-quarter portfolio rebalancing as the session saw the laggards of the quarter like Apple and Tesla gain, and the stars like Microsoft and Nvidia retreat.